The present study demonstrates for the first time that β-adrenergic inhibition can enhance the effect of radiotherapy on gastric cancer cells in vitro through the downregulation of NF-κB and modulation of downstream COX-2, EGFR and VEGF gene expression. Here, NFKB1 is linked to gastric cancer.